Related references
Note: Only part of the references are listed.Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models
Jack Phan et al.
HUMAN MOLECULAR GENETICS (2009)
Single Neuron Ubiquitin-Proteasome Dynamics Accompanying Inclusion Body Formation in Huntington Disease
Siddhartha Mitra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice
Chien-Wei Liao et al.
BMC INFECTIOUS DISEASES (2008)
A critical evaluation of adenosine A2A receptors as potentially Druggable targets in Huntington's disease
Patrizia Popoli et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients
Hyemyung Seo et al.
HUMAN MOLECULAR GENETICS (2008)
Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice
Jianjun Wang et al.
JOURNAL OF CELL BIOLOGY (2008)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Bjorkqvist et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Differential Activities of the Ubiquitin-Proteasome System in Neurons versus Glia May Account for the Preferential Accumulation of Misfolded Proteins in Neurons
Suzanne Tydlacka et al.
JOURNAL OF NEUROSCIENCE (2008)
Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies
Lynn Bedford et al.
JOURNAL OF NEUROSCIENCE (2008)
Revealing the Dynamics of the 20 S Proteasome Phosphoproteome A COMBINED CID AND ELECTRON TRANSFER DISSOCIATION APPROACH
Haojie Lu et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity
Marc Flajolet et al.
NATURE NEUROSCIENCE (2008)
Systemic administration of the adenosine A2A agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake
Susana Mingote et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
Paula van Tijn et al.
PROGRESS IN NEUROBIOLOGY (2008)
Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress
Takahiro Seki et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Role of proteasomes in disease
Burkhardt Dahlmann
BMC BIOCHEMISTRY (2007)
The ubiquitin-proteasome pathway in health and disease of the nervous system
Ashok N. Hegde et al.
TRENDS IN NEUROSCIENCES (2007)
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice
M. R. Domenici et al.
NEUROBIOLOGY OF DISEASE (2007)
Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB
Stefan Wiese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
Marta Valenza et al.
HUMAN MOLECULAR GENETICS (2007)
Global changes to the ubiquitin system in Huntington's disease
Eric J. Bennett et al.
NATURE (2007)
Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6
Fengxue Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease
Jesse M. Hunter et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Proteasomes: Machines for all reasons
George N. DeMartino et al.
CELL (2007)
Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease
Jonathan Wanderer et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2007)
Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease
Valerie Perrin et al.
MOLECULAR THERAPY (2007)
Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach
Ming-Chang Chiang et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Testing the possible inhibition of proteasome by direct interaction with ubiquitylated and aggregated huntingtin
Adriana G. Valera et al.
BRAIN RESEARCH BULLETIN (2007)
Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice
Alberto Martire et al.
NEUROSCIENCE LETTERS (2007)
Dysregulation of C/EBPα by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease
Ming-Chang Chiang et al.
HUMAN MOLECULAR GENETICS (2007)
Cardiac dysfunction in the R6/2 mouse model of Huntington's disease
Michael J. Mihm et al.
NEUROBIOLOGY OF DISEASE (2007)
Is the ubiquitin-proteasome system impaired in Huntington's disease?
Z. Ortega et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Interplay between protein synthesis and degradation in the CNS: physiological and pathological implications
Qunxing Ding et al.
TRENDS IN NEUROSCIENCES (2007)
Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease
Alessia Tarditi et al.
NEUROBIOLOGY OF DISEASE (2006)
The nuclear ubiquitin-proteasome system
Anna von Mikecz
JOURNAL OF CELL SCIENCE (2006)
Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG gamma as a therapeutic target
JS Bett et al.
HUMAN MOLECULAR GENETICS (2006)
A population pharmacokinetict pharmacodynamic analysis of regadenoson, an adenosine A(2A)-receptor agonist, in healthy male volunteers
Toufigh Gordi et al.
CLINICAL PHARMACOKINETICS (2006)
Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models
M Fujimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant huntingtin with expanded polyglutamine residues
MC Chiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model
SY Chou et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
M Tanaka et al.
NATURE MEDICINE (2004)
Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage
JS Fink et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion:: inhibition of chemokine induction
YJ Day et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Generalized brain and skin proteasome inhibition in Huntington's disease
H Seo et al.
ANNALS OF NEUROLOGY (2004)
Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates
H Doi et al.
FEBS LETTERS (2004)
The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases
CA Ross et al.
TRENDS IN CELL BIOLOGY (2004)
Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation
RR Ribchester et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach
DG Hay et al.
HUMAN MOLECULAR GENETICS (2004)
Partial agonists for A(3) adenosine receptors
ZG Gao et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin - A potential mechanism for loss of huntingtin function in Huntington's disease
A Busch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity
H Zhou et al.
JOURNAL OF CELL BIOLOGY (2003)
Characterization of the rat A2A adenosine receptor gene:: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system
YC Lee et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
C Zuccato et al.
NATURE GENETICS (2003)
The role of the ubiquitin/proteasome system in cellular responses to radiation
WH McBride et al.
ONCOGENE (2003)
Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy
B Ravikumar et al.
HUMAN MOLECULAR GENETICS (2003)
How the ubiquitin-proteasome system controls transcription
M Muratani et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Huntington's disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression
OA Andreassen et al.
NEUROBIOLOGY OF DISEASE (2002)
Weight loss in early stage of Huntington's disease
L Djoussé et al.
NEUROLOGY (2002)
Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses
S Sipione et al.
HUMAN MOLECULAR GENETICS (2002)
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2002)
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease
EYW Chan et al.
HUMAN MOLECULAR GENETICS (2002)
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
AW Dunah et al.
SCIENCE (2002)
Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin
A Wyttenbach et al.
HUMAN MOLECULAR GENETICS (2002)
Interaction of Huntington disease protein with transcriptional activator Sp1
SH Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription
KB Kegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
A Wyttenbach et al.
HUMAN MOLECULAR GENETICS (2001)
Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease
A Sittler et al.
HUMAN MOLECULAR GENETICS (2001)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation
S Waelter et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Activation of protein kinase A and atypical protein kinase C by A2A adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells
NK Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression
ST Suhr et al.
JOURNAL OF CELL BIOLOGY (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
Activation of Trk neurotrophin receptors in the absence of neurotrophins
FS Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity
NR Jana et al.
HUMAN MOLECULAR GENETICS (2000)
Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
PJ Muchowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
JS Steffan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2000)
Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract
Y Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease
A Wyttenbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
Share Paper
